Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Acq. announced
Talon Therapeutics, Inc. (TLON) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/28/2017 CT ORDER Form CT ORDER - Confidential treatment order
12/29/2016 CT ORDER Form CT ORDER - Confidential treatment order
07/29/2013 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
07/25/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
07/25/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
07/25/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/25/2013 POS AM Form POS AM - Post-Effective amendments for registration statement
07/19/2013 8-K Quarterly results
07/18/2013 SC 13D/A Warburg Pincus Private Equity X, L.P. reports a 0% stake in Talon Therapeutics, Inc.
07/18/2013 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/17/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Spectrum Pharmaceuticals Acquires Talon Therapeutics South San Francisco, Calif., July 17, 2013 – Talon Therapeutics, Inc. today announced that a subsidiary of Spectrum Pharmaceuticals, Inc. entered into an agreement to purchase approximately 89% of the outstanding shares of Talon directly from the Company’s principal stockholders. Spectrum also entered into an agreement with the Company under which the subsidiary of Spectrum will purchase additional shares from the Company that, together with the shares acquired from the Company’s principal stockholders, will represent in excess of 90% of the outstanding shares of Talon, and under which Spectrum will acquire the remaining outstanding shares of Company common stock through a “short-form” merger of the subsidiary of Spectrum into the Compan..."
05/15/2013 10-Q Quarterly Report for the period ended March 31, 2013
04/01/2013 10-K Annual Report for the period ended December 31, 2012
04/01/2013 8-K Quarterly results
Docs: "Talon Therapeutics, Inc. Reports Fourth Quarter and Year End 2012 Financial Results South San Francisco, California, April 1, 2013 - Talon Therapeutics, Inc., , today reported financial results for the fourth quarter and year ended December 31, 2012. 2012 Corporate Highlights ● FDA accelerated approval of Marqibo® for the treatment of Philadelphia chromosome negative adult acute lymphoblastic leukemia patients in second or greater relapse or whose disease has progressed following two or more prior lines of anti-leukemia therapy. ● Enrollment and dosing of the first patient in the Phase 3 confirmatory study of Marqibo®, named HALLMARQ, in adult patients with newly diagnosed Philadelphia chromosome negative ALL. ● Publication of the Marqibo® RALLY Study in the Journal of Cl..."
01/25/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Talon Therapeutics, Inc. 2010 Equity Incentive Plan, as amended through January 21, 2013"
01/15/2013 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/14/2013 SC 13D/A Warburg Pincus Private Equity X, L.P. reports a 92.4% stake in Talon Therapeutics, Inc.
01/11/2013 8-K Unregistered Sales of Equity Securities
01/07/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Talon Therapeutics, Inc. press release"
01/04/2013 8-K Appointed a new director
12/17/2012 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans
12/03/2012 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
11/16/2012 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/15/2012 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy